CN103142960B - Medicament for treating skin diseases - Google Patents
Medicament for treating skin diseases Download PDFInfo
- Publication number
- CN103142960B CN103142960B CN201310090401.6A CN201310090401A CN103142960B CN 103142960 B CN103142960 B CN 103142960B CN 201310090401 A CN201310090401 A CN 201310090401A CN 103142960 B CN103142960 B CN 103142960B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- folium
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a medicament for treating skin diseases. The medicament is prepared from the following substances in parts by weight: 5-10 parts of scrophularia ningpoensis, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of angelica, 5-15 parts of inula flower, 10-30 parts of vaccaria, 1-15 parts of herba aristolochiae, 10-20 parts of saposhnikovia divaricata, 15-30 parts of ephedra, 20-30 of belleric terminalia fruit, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of folium isatidis, 10-30 parts of circium japonicum, 1-20 parts of lonicerae flos, 15-20 parts of murraya paniculata, 10-20 parts of semen pharbitidis, 15-20 parts of herba inulae, 15-30 parts of herba sarcandrae, 10-20 parts of clinopodium polycephalum, 10-25 of senna, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of the root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of teasel root and 10-25 parts of rhododendron molle. All the components of the medicament are natural materials, and the medicament for treating perniosis is highly safe, has a definite treatment effect and is suitable for large-scale clinical popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of dermopathic medicament for the treatment of.
Background technology
Medically, dermatosis is the disease of relevant skin, is one of the commonly encountered diseases that has a strong impact on people ' s health, frequently-occurring disease, as leprosy, scabies, mycosis, bacterial skin infections etc.Dermatosis is that skin (comprising hair and first) is subject to after the impact of internal and external factor, and its form, 26S Proteasome Structure and Function all change, and produces pathological process, and produces accordingly various clinical priority performances.How low weight dermopathic sickness rate is very high,, often not unhealthful, even can threat to life but minority is heavier.
Summary of the invention
The object of this invention is to provide a kind of dermopathic medicament for the treatment of.
In order to realize object of the present invention, the invention provides a kind of dermopathic medicament for the treatment of, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Folium Isatidis 10-25 part, Radix Cirsii Japonici 10-30 part, Flos Lonicerae 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the dermopathic medicament for the treatment of of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Folium Isatidiss, 21 parts of Radix Cirsii Japonicis, 16 parts of Flos Lonicerae, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the dermopathic medicament for the treatment of of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 7 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 22 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 21 grams of the Radixs Angelicae Dahuricae, 13 grams of Flos Inulaes, 28 grams of Semen Vaccariae, 11 grams of Herba Aristolochiaes, 17 grams of Radix Saposhnikoviaes, 24 grams, Herba Ephedrae, 27 grams of Fructus Terminaliae Billericaees, 18 grams of Radix Morindae Officinaliss, 17 grams of Herba Chelidoniis, 23 grams of Folium Isatidiss, 21 grams of Radix Cirsii Japonicis, 16 grams of Flos Lonicerae, 16 grams of Folium Et Cacumen Murrayae, 17 grams of Semen Pharbitidiss, 19 grams of Herba Inulae, 15 grams of Herba Sarcandraes, 14 grams of Herba Clinopodii, 21 grams of Folium Sennae, 11 grams of Radix seu Herba Gei aleppici, 13 grams of Radix Rhapontici, 23 grams of Folium Rhododendri Daurici, 24 grams of Herba Potentillae Discoloris, 14 grams of Calyx Seu Fructus Physaliss, 25 grams of Cortex Mori, 26 grams of Herba Eupatorii Lindleyanis, 24 grams of 16 grams of Radix Dipsacis and Flos Rhododendri Mollis, add 2100 milliliters, water, in being housed, at 80 ℃, heats 4 hours by the flask of condensing tube, filter.Filtrate is concentrated into 800 milliliters, obtains decoction of the present invention.
Experimental example
Scabies is the dermatosis causing due to skin infection sarcoptic mite.The infectiousness of scabies is very strong, can propagate by close contact.Its sign is that the violent rash of skin is itched, and erythra is mainly in skinfold place, particularly pudendum, and easily causes the sequela such as scabies tuberosity.Scabies is descriptive herein, not protection scope of the present invention is limited.
60 routine cases are out-patient, male's 30 examples, women's 30 examples; Age 12-60 year, average 28 years old; The course of disease 1 day-12 months.Skin lesion all occurs in the thin tender place of skin, and 2 places, more than 10 places, very spread all over whole body at most at least.Show as pimple more, little of needle point or the grain of rice, or be phlysis, pruritus with night for very.
Use the decoction of preparation in embodiment 1 to treat, every day 2 times, each oral 50 milliliters.Using continuously 3 days is a course for the treatment of.
Efficacy assessment standard: cure: without pruritus, pimple, vesicle disappear, and choose in non-tunnel or tunnel without acaricide; Effective: time have a pruritus, pimple, vesicle disappear, and in non-tunnel or tunnel, without acaricide, choose; Invalid: pruritus still, there are pimple, vesicle, have in tunnel or tunnel and can have acaricide to choose.
In treatment, by inspection, whole 60 routine patients are without pruritus after treating 1 course for the treatment of, and pimple, vesicle disappear, and in non-tunnel or tunnel, without acaricide, choose, and all meet the standard of healing.And there is not untoward reaction in patient in therapeutic process.
Claims (2)
1. treat dermopathic medicament for one kind, it is characterized in that, it is to be made by the raw material of Chinese medicine of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Folium Isatidis 10-25 part, Radix Cirsii Japonici 10-30 part, Flos Lonicerae 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the dermopathic medicament for the treatment of according to claim 1, it is characterized in that, it is to be made by the raw material of Chinese medicine of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Folium Isatidiss, 21 parts of Radix Cirsii Japonicis, 16 parts of Flos Lonicerae, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310090401.6A CN103142960B (en) | 2013-03-21 | 2013-03-21 | Medicament for treating skin diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310090401.6A CN103142960B (en) | 2013-03-21 | 2013-03-21 | Medicament for treating skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103142960A CN103142960A (en) | 2013-06-12 |
| CN103142960B true CN103142960B (en) | 2014-02-05 |
Family
ID=48541469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310090401.6A Expired - Fee Related CN103142960B (en) | 2013-03-21 | 2013-03-21 | Medicament for treating skin diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142960B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214261A (en) * | 1998-10-21 | 1999-04-21 | 余际康 | Oral medicine for curing dermatosis |
-
2013
- 2013-03-21 CN CN201310090401.6A patent/CN103142960B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214261A (en) * | 1998-10-21 | 1999-04-21 | 余际康 | Oral medicine for curing dermatosis |
Non-Patent Citations (2)
| Title |
|---|
| 凉血10 法在皮肤科的临床运用;戴蜀平;《辽宁中医学院学报》;20031130;第5卷(第4期);352－353 * |
| 戴蜀平.凉血10 法在皮肤科的临床运用.《辽宁中医学院学报》.2003,第5卷(第4期),352－353. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103142960A (en) | 2013-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103100075B (en) | Medicament for treating eczema | |
| CN103393895B (en) | Bone-setting traditional Chinese medicine decoction and preparation method thereof | |
| CN103142959A (en) | Medicament for treating urticaria | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN103142960B (en) | Medicament for treating skin diseases | |
| CN103055055A (en) | Traditional Chinese medicine for treating skin diseases | |
| CN102294007A (en) | Medicament for treating urticaria | |
| CN102068511A (en) | External medicament for treating lumbar vertebral disc protrusion | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN102526385B (en) | Medicament for treating climacteric syndrome | |
| CN101810831B (en) | Medicament for treating gynecological diseases | |
| CN103157091A (en) | Drug for treating empyrosis | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
| CN103157090A (en) | Medicament for treating diarrhea | |
| CN103272192B (en) | Medicament for treating perianal abscess | |
| CN103142958A (en) | Medicament for treating perniosis | |
| CN102302583B (en) | Medicinal composition for reducing swelling and alleviating pain | |
| CN103142972B (en) | Medicine for treating children dermatosis | |
| CN103055051B (en) | Liquid for treating burn and scald | |
| CN103110924A (en) | Medicine for treating hemorrhoids | |
| CN103142955A (en) | Medicine for treating cold | |
| CN103142984B (en) | Medicine for treating rheumatism | |
| CN103142979B (en) | Medicine for treating irregular menstruation | |
| CN103110927A (en) | Medicine for treating gingivitis | |
| CN103463324B (en) | Medicinal composition for preventing or treating oral ulcer and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHENG HAIYAN Free format text: FORMER OWNER: LI JUN Effective date: 20131230 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zheng Haiyan Inventor before: Li Jun |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI JUN TO: ZHENG HAIYAN Free format text: CORRECT: ADDRESS; FROM: 272000 JINING, SHANDONG PROVINCE TO: 272100 JINING, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20131230 Address after: 272100 Department of Dermatology, first people's Hospital, 6 health Road, Shandong, Jining, China Applicant after: Zheng Haiyan Address before: The Affiliated Hospital of Medical College of Jining No. 79 of 272000 cities in Shandong province Jining City Central Guhuai Road Applicant before: Li Jun |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140205 Termination date: 20150321 |
|
| EXPY | Termination of patent right or utility model |